The 10 Drugs Getting Medicare Price Cuts & Bitcoin's Big Win Over the SEC
Morning Brew Daily
00:00
Pharmaceutical Lobbying and Legal Shifts
This chapter explores the implications of the Inflation Reduction Act on drug pricing and highlights significant pharmaceutical industry lobbying efforts. It also discusses a federal court ruling on the SEC's decisions regarding cryptocurrency, the rise of Bitcoin ETFs, and 3M's massive settlement over defective products. Additionally, it examines ongoing legal tactics companies use to handle mass torts and the shifting landscape of corporate accountability.
Play episode from 03:32
Transcript
